Table 4

Plasma concentrations of amifostine perfusing the gastrointestinal tract, splanchnic region or kidneys (equivalent to CCA), lungs (CPA), and liver (Cave) after three sequentially escalated intravenous infusions of amifostine

Dose RateCCACPACaveSignificance4-a
μmol/min/kg μM
0.1252.7 ± 1.02.9 ± 1.21.6 ± 0.40.066
0.50014.7 ± 4.215.8 ± 4.614.2 ± 4.20.759
1.00 (n)27.8 ± 8.2  (10)29.2 ± 8.8  (10)29.0 ± 8.5  (5)0.924
  • Data are reported as mean ± S.D. (n = 5–10 dogs).

  • 4-a values were determined by ANOVA with repeated measures.